Indaptus Therapeutics, INC. (INDP) — 10-Q Filings

All 10-Q filings from Indaptus Therapeutics, INC.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (5)

Indaptus Therapeutics Faces Going Concern Doubt Amid Rising R&D Costs — Nov 12, 2025 Risk: high
Indaptus Therapeutics, Inc. (INDP) reported a net loss of $12.7 million for the nine months ended September 30, 2025, an increase from a net loss of $10.9 milli
Indaptus Therapeutics Files Q1 2025 10-Q — May 14, 2025 Risk: low
Indaptus Therapeutics, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Intec Parent Inc., is incorporated i
Indaptus Therapeutics Files Q3 2024 10-Q — Nov 12, 2024 Risk: low
Indaptus Therapeutics, Inc. filed its quarterly report for the period ending September 30, 2024. The company, formerly known as Intec Parent Inc. until April 14
Indaptus Therapeutics Files Q2 2024 10-Q — Aug 12, 2024 Risk: medium
Indaptus Therapeutics, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported financial results and provided updates on its operations. S
Indaptus Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — May 8, 2024 Risk: low
Indaptus Therapeutics, Inc. (INDP) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Indaptus Therapeutics, Inc. filed a 10-Q for the quarterly perio

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX